The Red Light Report cover image

The Red Light Report

Altering the Gut Microbiome in Parkinson’s Disease via Red Light Therapy

Feb 3, 2022
35:45

Parkinson’s disease is the second most common age-related neurodegenerative disorder after Alzheimer’s disease. An estimated seven to 10 million people worldwide have Parkinson’s disease. Men are 1.5 times more likely to have Parkinson’s than women. The disease affects patients’ quality of life, making social interaction more difficult and worsening their financial condition, due to the medical expenses associated with the disease.

These are just the tip of the iceberg​, as it relates to sobering stats on Parkinson's disease...​

On this week's solosode of The Red Light Report, I decided to report on some hot-off-the-press research about -- you guessed it -- red light therapy and Parkinson's disease. We typically associate Parkinson's as just a disease of the brain. But what if I told you that your gut microbiome may playing a larger role in the disease via the gut-brain axis?

​​It turns out that most individuals with Parkinson's have the opposite desired ratio of bacteria ('good' vs. 'bad') that is seen in a healthy, vibrant gut environment. ​​This research article, which was published in early January, uncovers the amazing potential that red light therapy, specifically near-infrared light, has on improving the ratio of 'good' bacteria to 'bad' bacteria in the gut. 

This is a very exciting piece of research, as it further demonstrates the versatile healing abilities of red light therapy and just how resilient our bodies can be when given what it wants. In this case, the gut wanted some NIR light. Learn lots and enjoy!

-

Dr. Mike Belkowski Discusses the following:

Upcoming events:

  • Biohacking Congress 2022
    • Las Vegas - March 19 & 20
    • Boston - June 11 & 12
    • Miami - October 22 & 23
  • The Health Optimization Summit in London - March 28 & 29
  Research:
  • From the Journal of Personalized Medicine - Microbiome Changes in Humans with Parkinson’s Disease after Photobiolodulation Therapy: a Retrospective Study by Brian Bicknell and his cohort
    • The introduction
    • The types of participants they used
    • The discussion
    • The conclusion
  • How Parkinson’s disease is due to mitochondrial dysfunction
- Citation:
Microbiome Changes in Humans with Parkinson's Disease after Photobiomodulation Therapy: A Retrospective Study -

To learn more about red light therapy and shop for the highest-quality red light therapy products, visit www.biolight.shop

-

Stay up-to-date on social media:

Instagram

YouTube

Facebook

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode